3 weeks ago
Andhra Health Secretary Urges Zero Tolerance for Poor-Quality Medicines
In Vijayawada, a city in India, important people who watch over medicines held a big meeting.
They wanted to talk about making sure medicines are safe and good.
The top health leader of Andhra Pradesh said the state will not accept medicines of poor quality.
He said medicines made in Andhra Pradesh are used by sick people in many countries.
So keeping them safe helps people everywhere.
Experts from India and the United States shared ideas at the meeting.
They talked about checking medicine factories and testing products carefully.
They also discussed new rules that medicine makers must follow.
Everyone agreed that working together keeps patients safe and healthy.
Andhra Pradesh health secretary G. Veerapandian called for zero tolerance towards poor-quality medicines, citing recent instances of international contamination.
He inaugurated a one-day regulatory workshop titled 'Ensuring Drug Quality: Scientific Approach in Regulations, Standards and Inspections' in Vijayawada.
The workshop was jointly organised by the AP Drugs Control Administration, US Pharmacopeia (USP), AIDCOC and the US FDA India Office.
Officials stressed that medicines manufactured in Andhra Pradesh serve patients worldwide, urging stronger scientific inspections and evidence-based regulatory decisions.
More than 75 drug inspectors, government analysts, regulators, industry representatives and technical experts from across Andhra Pradesh attended the workshop.
- Who
- Andhra Pradesh health secretary G. Veerapandian, alongside officials including US FDA India Office Country Director Gregory Smith, USP India Site Head Girish Kapur and AP drugs control administration director M. Panduranga Prasad
- What
- Called for zero tolerance towards poor-quality medicines and inaugurated a one-day regulatory workshop on drug quality
- Where
- Vijayawada, Andhra Pradesh, India
- When
- On a Friday; the article does not state a specific date
- Why
- To strengthen scientific regulation, standards and inspections so medicines manufactured in Andhra Pradesh stay safe for patients worldwide
Key facts
- Event
- One-day regulatory workshop 'Ensuring Drug Quality: Scientific Approach in Regulations, Standards and Inspections'
- Location
- Vijayawada, Andhra Pradesh, India
- Organizers
- AP Drugs Control Administration, US Pharmacopeia (USP), AIDCOC and US FDA India Office
- Key speaker
- G. Veerapandian, Andhra Pradesh health secretary
- Theme
- Zero tolerance for poor-quality medicines; science-based regulation
- Attendance
- More than 75 drug inspectors, government analysts, regulators, industry representatives and technical experts
- Topics discussed
- Revised Schedule M norms, scientific inspection methods, evidence-based regulatory decision-making
Quotes
G. Veerapandian
Andhra Pradesh Health Secretary
“Regulation should enable quality, innovation and public confidence. Our responsibility extends beyond state and national boundaries because medicines manufactured in Andhra Pradesh serve patients across the world.”
deccanchronicle.com
“Medicine quality is fundamental to patient trust and emphasised that collaboration among regulators, scientists and industry experts would strengthen science‑based regulation and patient safety.”
deccanchronicle.com
Gregory Smith
US FDA India Office Country Director
“Every inspection, laboratory result and regulatory decision ultimately affects patients and stressed the importance of scientific collaboration and sharing best practices to strengthen global regulatory systems.”
deccanchronicle.com










